Semnur Pharmaceuticals, Inc. (SMNR)
14.00
+5.00
(+55.56%)
USD |
OTCM |
Dec 15, 16:00
Semnur Pharmaceuticals Total Liabilities (Quarterly): 15.37M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Scilex Holding Co. | 455.60M |
| CEL-SCI Corp. | 13.31M |
| AIM ImmunoTech, Inc. | 11.57M |
| IGC Pharma, Inc. | 1.651M |
| NovaBay Pharmaceuticals, Inc. | 1.853M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 0.774M |
| Shareholders Equity (Quarterly) | -14.59M |
| Debt to Equity Ratio | -0.6724 |
| Current Ratio | 0.0085 |
| Net Debt Paydown Yield | -2.98% |